Blue Heron Capital Company Profile

11:37 EDT 19th September 2018 | BioPortfolio

Blue Heron Capital is an innovative alternative investment group representing a proprietary network of executives, entrepreneurs, high net worth individuals and family offices. We focus on investing in growth equity and lower market buyout opportunities. Blue Heron only invests in companies where someone from our network adds real and relevant value. Once committed to a deal, our value-added lead investor represents our firm as a board member to help drive company growth. Our commitment is to build fruitful and sustainable partnerships between management and our investor network. To learn more, please visit

News Articles [946 Associated News Articles listed on BioPortfolio]

Heron leaps on strong results for anesthetic product

Shares of US biotech firm Heron Therapeutics climbed 32% to $28.50 in early US trading Monday after…

Shire’s Japanese takeover confirmed, but what does it say about London’s blue-chips?

Deal capital is clearly sloshing around blue-chip boardrooms, but, are we seeing a run of takeovers near the top of the market?

Brii Biosciences launches with $260mm

Brii Biosciences has launched with committed funding of $260mm from Arch Venture Partners, 6 Dimensions Capital, Boyu Capital, Yunfeng Capital, Sequoia Capital, and Blue Pool Capital.

Cigna And Blue Cross Plans Buy Stake In Telehealth's MDLive

MDLive has landed a $50 million investment from investors including Cigna, High Velocity Capital and Health Care Service Corp., the parent of five Blue Cross and Blue Shield plans.

Heron's non-opioid pain drug succeeds in Phase 3, lifting shares

Treatment with HTX-011 following surgery reduced both pain intensity and need for opioids — results Heron hopes can secure a broad label from the FDA.

Deals this week: Heron Therapeutics, EyePoint Pharmaceuticals, Celgene Corporation

US-based specialist pharmaceutical company Heron Therapeutics has raised $200m through an underwritten public offering of shares of its common stock. The...Read More... The post Deals this week: Hero...

4 BCBS plans now cover Interpace's molecular thyroid tests

Blue Cross Blue Shield of Arizona, Blue Cross Blue Shield of South Carolina, Wellmark Blue Cross Blue Shield of South Dakota  -More- 

Heron soars after its painkiller agent reduces pain and opioid use post-surgery at Phase 3

Heron Therapeutics has been buoyed by the news that its painkiller agent HTX-011 met all of its primary and secondary endpoints in Phase 3 studies investigating its efficacy in relieving pain and opio...

PubMed Articles [525 Associated PubMed Articles listed on BioPortfolio]

What is the association between social capital and diabetes mellitus? A systematic review.

Social capital has been included as an element that could influence the self-perception of health, mortality and mental diseases. We systematically reviewed papers that studied the influence of social...

"Who'll do all these if I'm not around?": Bonding social capital and health and well-being of inpatients.

Although social capital influences health-related decisions and behavioural patterns in many developing countries, minimal attention has been paid to the nuances of its effect on healthcare. This pape...

Association Between Community Social Capital and Hospital Readmission Rates.

Hospital readmissions remain frequent, and are partly attributable to patients' social needs. The authors sought to examine whether local community levels of social capital are associated with hospita...

Is community social capital associated with subjective symptoms of dementia among older people? A cross-sectional study in Japan.

Many studies have reported the preventive effects of community social capital on health outcomes, such as mortality and incidence of diseases. However, evidence on the association between community so...

Social capital interventions in public health: A systematic review.

Despite two decades of research on social capital and health, intervention studies remain scarce. We performed a systematic review on social capital interventions in public health and searched the Pub...

Clinical Trials [273 Associated Clinical Trials listed on BioPortfolio]

Social Capital and Engagement in Care Among Young Black Men Who Have Sex With Men Living With HIV

The study is a randomized controlled trial to evaluate the social capital intervention versus a general health promotion intervention (Health for Life; H4L) among groups of Young black men...

MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN)

The goal of this clinical research study is to compare methylene blue (an oral rinse) to standard therapy to learn if one is better, the same, or worse than the other in controlling mucosi...

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

Evaluation of Effectiveness of Blue Code Team After In-hospital Cardiopulmonary Arrest

This study aimed to retrospectively examine patients evaluated by the Code Blue team on a Code Blue call in our hospital between 2016-2017. Primary outcome: an examination of the survival...

Interaction Between Anaesthetics and Methylene Blue

We hypothesized that pre-treatment with methylene blue could potentiate the effects of general anaesthetic agents in patients undergoing parathyroidectomy

Companies [1346 Associated Companies listed on BioPortfolio]

Blue Heron Biotechnology Incorporated

Blue Heron produces and sells high quality custom reagents for life science research using its proprietary high-throughput manufacturing technologies. Blue Heron's first service, GeneMaker, makes perf...

Blue Heron Capital

Blue Heron Capital is an innovative alternative investment group representing a proprietary network of executives, entrepreneurs, high net worth individuals and family offices. We...


Blue Heron Bio's GeneMaker® can synthesize any gene regardless of sequence, complexity, or size with 100% accuracy. Save time and money by ordering perfect clones from Blue Heron Bio. Go to ORDERING ...

Heron Health

HERON is a privately held healthcare consultancy founded in the UK in 1999 by Paul Howard, John Kerrigan, and Chris Knight. Following over a decade of growth, the Company is still wholly owned and o...

Blue Wolf Capital Partners LLC

Blue Wolf Capital Partners LLC is a private equity firm that invests in companies in which effective management of relationships with complex constituencies, such as government an...

More Information about "Blue Heron Capital" on BioPortfolio

We have published hundreds of Blue Heron Capital news stories on BioPortfolio along with dozens of Blue Heron Capital Clinical Trials and PubMed Articles about Blue Heron Capital for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Blue Heron Capital Companies in our database. You can also find out about relevant Blue Heron Capital Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record